Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study, Evaluation of Low Dose Natural Human Interferon Alpha Administered by the Oral Mucosal Route in the Treatment of Behçet's Disease

NCT00483184 is registered in ClinicalTrials.gov with Nobel Pharmaceuticals as lead sponsor.

NCT NCT00483184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00483184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study, Evaluation of Low Dose Natural Human Interferon Alpha Administered by the Oral Mucosal Route in the Treatment of Behçet's Disease
Lead sponsor
Nobel Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2006
Completion date
April 30, 2008
Enrollment
84 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

behcet disease, behcet syndrome, mucocutaneous ulceration